These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 13565388)

  • 1. Studies of serum cholesterol and lipid phosphorus in coronary heart disease.
    GUPTA KK; IYER PV; NATH HP
    Metabolism; 1958 Jul; 7(4 Pt 1):349-54. PubMed ID: 13565388
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum lipid patterns in coronary artery disease.
    Arora OP; Dhanda PC
    J Assoc Physicians India; 1968 Nov; 16(11):863-8. PubMed ID: 5713491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rhythm of diurnal variations in lipid metabolism indicators in ischemic heart disease].
    Zaslavskaia RM; Akhmetov KZh
    Sov Med; 1974 Jul; 0(7):148-9. PubMed ID: 4410793
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum lipid levels and their relationship with ischemic heart disease in pigs.
    Arora RB; Tayal G; Tariq M
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():795-803. PubMed ID: 4806680
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of cholesterol/phospholipid ratio and triene/tetraene ratio in coronary heart disease.
    Tanksale KG
    J Postgrad Med; 1978 Jul; 24(3):158-63. PubMed ID: 722612
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correlation of cholesterol and phospholipids in blood of subjects with coronary atherosclerosis and myocardial infarct].
    SIDOROVA LN
    Klin Med (Mosk); 1958 Aug; 36(8):63-6. PubMed ID: 13588885
    [No Abstract]   [Full Text] [Related]  

  • 7. Total serum cholesterol, cholesterol-lipid phosphorus ratio, and Sf 12-20 concentration in hypertension, diabetes, and coronary artery disease.
    KATZ LB; RHODES GJ; GEORGE RS; MOSES C
    Am J Med Sci; 1953 Feb; 225(2):120-8. PubMed ID: 13016551
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood lipid variations in patients with hypercholesterolaemia and coronary artery disease. Part I.
    SEGALL S; NEUFELD AH
    Can Med Assoc J; 1960 Sep; 83(10):521-4. PubMed ID: 14444542
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of estrogens on the plasma lipids in coronary artery disease.
    OLIVER MF; BOYD GS
    Am Heart J; 1954 Mar; 47(3):348-59. PubMed ID: 13124250
    [No Abstract]   [Full Text] [Related]  

  • 10. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components.
    Ghafoorunissa
    Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of trilodothyroacetic acid on serum cholesterol and phospholipids in patients with coronary artery diseases.
    CHURCH G; LAWRIE TD; PIRRIE R
    Scott Med J; 1957 Jul; 2(7):293-8. PubMed ID: 13454834
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum cholesterol in relation to blood groups in ischaemic heart disease.
    Chakraborti S; Banerjee PK
    J Indian Med Assoc; 1974 Sep; 63(5):150-2. PubMed ID: 4448914
    [No Abstract]   [Full Text] [Related]  

  • 14. Shellfish consumption and risk of coronary heart disease.
    Matheson EM; Mainous AG; Hill EG; Carnemolla MA
    J Am Diet Assoc; 2009 Aug; 109(8):1422-6. PubMed ID: 19631050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a diet rich in fat, unsaturated fatty acids, phospholipids and vitamin B on the blood-cholesterol levels.
    BLOEM TF; VAN HANDEL E; NEUMANN H
    Bull Schweiz Akad Med Wiss; 1957 Apr; 13(1-4):348-55. PubMed ID: 13436982
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum sex hormones in premenopausal women with coronary heart disease.
    Mohamad MJ; Karayyem M; Mohammad MA; Al-Alami J; Al-Hader A
    Neuro Endocrinol Lett; 2006 Dec; 27(6):758-62. PubMed ID: 17186999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composition of LDL particle discriminates between hypercholesterolaemic persons with and without symptoms of coronary heart disease.
    Van Jaarsveld H; Pool GF; Bester CJ
    Ann Clin Biochem; 2004 May; 41(Pt 3):213-9. PubMed ID: 15117435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and particularities of dyslipidaemia in subjects with coronary heart disease.
    Agoşton-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(4):341-7. PubMed ID: 18767409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.